Are DCM Shriram Fine Chemicals Ltd latest results good or bad?
2026-05-20 19:25:57DCM Shriram Fine Chemicals Ltd's latest financial results for Q4 FY26 reveal significant operational challenges. The company reported a net loss of ₹3.83 crores, marking a substantial decline compared to the previous year, and this is the third consecutive quarter of losses. The operating margin turned negative at -2.71%, a stark contrast to the positive margin of 6.78% in Q4 FY25, indicating a complete erosion of profitability. Net sales for the quarter were ₹93.08 crores, reflecting a slight year-on-year decline of 0.29% and a more pronounced quarter-on-quarter decrease of 3.99%. This drop in sales represents the lowest quarterly figure in the company’s recent history, highlighting ongoing operational distress. The operating profit (PBDIT excluding other income) fell to ₹-2.51 crores, a dramatic shift from the ₹7.63 crores reported in the same quarter last year. The financial metrics illustrate a concer...
Read full news article
DCM Shriram Fine Chemicals Q4 FY26: Steep Losses Mount as Operational Crisis Deepens
2026-05-20 16:55:47DCM Shriram Fine Chemicals Ltd., a micro-cap commodity chemicals manufacturer with a market capitalisation of ₹234.00 crores, reported a devastating quarterly loss in Q4 FY26, marking a dramatic reversal from profitability just a year ago. The company posted a consolidated net loss of ₹3.83 crores for the March 2026 quarter, a stark contrast to the ₹4.42 crores profit recorded in Q4 FY25, representing a year-on-year decline of 260.25%. The stock reacted sharply to the results, declining 4.97% to ₹26.94 in Tuesday's trading session, reflecting investor concerns about the company's deteriorating operational performance.
Read full news articleBoard Meeting Outcome for Outcome Of Board Meeting For Apporval Of Audited Financial Results For The Quarter And Year Ended March 31 2026 And Recommendation Of Final Dividend For The Financial Year March 31 2026 Subject To The Approval Of Shareholders.
19-May-2026 | Source : BSEOutcome of Board Meeting for apporval of audited financial results for the quarter and year ended March 31 2026 and Recommendation of final dividend for the financial year March 31 2026 subject to the approval of shareholders.
Audited Financial Results (Both Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2026 And Outcome Of Board Meeting.
19-May-2026 | Source : BSEAudited financial results (both standalone and Consolidated) fo rthe quarter and Financial year ended March 31 2026 and Outcome of Board Meeting.
Corporate Action-Board approves Dividend
19-May-2026 | Source : BSERecommendation of final dividend for FY 2025-26
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






